Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of ARS 343.20 trillion. The enterprise value is 375.92 trillion.
| Market Cap | 343.20T |
| Enterprise Value | 375.92T |
Important Dates
The last earnings date was Tuesday, October 28, 2025.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | Mar 12, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -3.84% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 37.34% |
| Float | 1.83B |
Valuation Ratios
The trailing PE ratio is 17.40 and the forward PE ratio is 14.17.
| PE Ratio | 17.40 |
| Forward PE | 14.17 |
| PS Ratio | 4.44 |
| PB Ratio | 5.60 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.79 |
| P/OCF Ratio | 11.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.39, with an EV/FCF ratio of 14.01.
| EV / Earnings | 19.06 |
| EV / Sales | 4.64 |
| EV / EBITDA | 10.39 |
| EV / EBIT | 12.80 |
| EV / FCF | 14.01 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.72.
| Current Ratio | 0.88 |
| Quick Ratio | 0.58 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 1.27 |
| Debt / FCF | 1.64 |
| Interest Coverage | 18.35 |
Financial Efficiency
Return on equity (ROE) is 32.62% and return on invested capital (ROIC) is 16.78%.
| Return on Equity (ROE) | 32.62% |
| Return on Assets (ROA) | 12.13% |
| Return on Invested Capital (ROIC) | 16.78% |
| Return on Capital Employed (ROCE) | 27.17% |
| Revenue Per Employee | 1.02B |
| Profits Per Employee | 259.95M |
| Employee Count | 75,883 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, Novartis AG has paid 2.79 trillion in taxes.
| Income Tax | 2.79T |
| Effective Tax Rate | 12.40% |
Stock Price Statistics
The stock price has increased by +44.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +44.04% |
| 50-Day Moving Average | 46,910.30 |
| 200-Day Moving Average | 37,717.58 |
| Relative Strength Index (RSI) | 44.92 |
| Average Volume (20 Days) | 334 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of ARS 77.26 trillion and earned 19.73 trillion in profits. Earnings per share was 10,003.28.
| Revenue | 77.26T |
| Gross Profit | 58.91T |
| Operating Income | 28.03T |
| Pretax Income | 22.50T |
| Net Income | 19.73T |
| EBITDA | 34.16T |
| EBIT | 28.03T |
| Earnings Per Share (EPS) | 10,003.28 |
Balance Sheet
The company has 13.25 trillion in cash and 43.89 trillion in debt, giving a net cash position of -30,636.16 billion.
| Cash & Cash Equivalents | 13.25T |
| Total Debt | 43.89T |
| Net Cash | -30,636.16B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 61.33T |
| Book Value Per Share | 31,662.76 |
| Working Capital | -5,210.64B |
Cash Flow
In the last 12 months, operating cash flow was 28.88 trillion and capital expenditures -2,051.64 billion, giving a free cash flow of 26.83 trillion.
| Operating Cash Flow | 28.88T |
| Capital Expenditures | -2,051.64B |
| Free Cash Flow | 26.83T |
| FCF Per Share | n/a |
Margins
Gross margin is 76.25%, with operating and profit margins of 36.29% and 25.53%.
| Gross Margin | 76.25% |
| Operating Margin | 36.29% |
| Pretax Margin | 29.13% |
| Profit Margin | 25.53% |
| EBITDA Margin | 44.21% |
| EBIT Margin | 36.29% |
| FCF Margin | 34.73% |
Dividends & Yields
This stock pays an annual dividend of 624.65, which amounts to a dividend yield of 1.22%.
| Dividend Per Share | 624.65 |
| Dividend Yield | 1.22% |
| Dividend Growth (YoY) | 34.57% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 54.32% |
| Buyback Yield | 3.84% |
| Shareholder Yield | 5.06% |
| Earnings Yield | 5.75% |
| FCF Yield | 7.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Oct 22, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novartis AG has an Altman Z-Score of 3.8 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.8 |
| Piotroski F-Score | 7 |